Skip to product information
1 of 1

PGC1α Recombinant Rabbit mAb (S-1199-234)

PGC1α Recombinant Rabbit mAb (S-1199-234)

Catalog Number: S0B1104 Application: WB Reactivity: Mouse,Rat Conjugation: Unconjugated Brand: Starter
Price:
Regular price $130.00 SGD
Regular price Sale price $130.00 SGD
Size:
For shipping services or bulk orders, you may request a quotation.
Secure checkout with
View full details

Product Details

Product Specification


Host Rabbit
Antigen PGC1α
Synonyms Peroxisome proliferator-activated receptor gamma coactivator 1-alpha; PGC-1-alpha; PPAR-gamma coactivator 1-alpha; PPARGC-1-alpha; PPARGC1A; LEM6; PGC1; PGC1A; PPARGC1
Immunogen Synthetic Peptide
Location Cytoplasm, Nucleus
Accession Q9UBK2
Clone Number S-1199-234
Antibody Type Recombinant mAb
Isotype IgG
Application WB
Reactivity Ms, Rt
Positive Sample mouse kidney, mouse heart, rat kidney, rat heart
Predicted Reactivity Pg, Bv
Purification Protein A
Concentration 0.25 mg/ml
Conjugation Unconjugated
Physical Appearance Liquid
Storage Buffer

PBS, 40% Glycerol, 0.05% BSA, 0.03% Proclin 300

Stability & Storage

12 months from date of receipt / reconstitution, -20 °C as supplied

Dilution


application dilution species
WB 1:5000 Ms, Rt

Background

PGC1α (Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha) is a transcriptional coactivator that plays a pivotal role in regulating energy metabolism and is implicated in various biological processes. PGC1α acts as a coactivator for several nuclear receptors and transcription factors, enhancing their transcriptional activity. It is involved in the regulation of genes that are crucial for adaptive thermogenesis and energy metabolism. PGC1α coordinates the expression of multiple genes involved in glucose and fatty acid metabolism, playing a significant role in metabolic reprogramming in response to dietary changes. It is also involved in the regulation of circadian rhythms and energy metabolism by activating RORA and RORC, which in turn control the oscillatory expression of clock genes such as ARNTL/BMAL1 and NR1D1. PGC1α has been considered a potential therapeutic target for treating type 2 diabetes, obesity, cardiomyopathy, and other metabolic disorders. PGC1α can suppress cholesterol synthesis and reduce serum cholesterol levels. It upregulates the expression of genes like Insig-1 and Insig-2, which inhibit cholesterol synthesis in cells like HepG2. It also promotes the transformation of cholesterol into bile acids, thereby affecting cholesterol metabolism and serum cholesterol levels. Moreover, PGC1α is a key regulator of mitochondrial biogenesis and function, which is crucial for energy production and cellular metabolism. It is involved in the adaptive response to changes in energy demand and nutrient availability.

Picture

Western Blot

WB result of PGC1α Recombinant Rabbit mAb
Primary antibody: PGC1α Recombinant Rabbit mAb at 1/5000 dilution
Lane 1: mouse kidney lysate 20 µg
Lane 2: mouse heart lysate 20 µg
Secondary antibody: Goat Anti-Rabbit IgG, (H+L), HRP conjugated at 1/10000 dilution Predicted MW: 91 kDa
Observed MW: 110 kDa

WB result of PGC1α Recombinant Rabbit mAb
Primary antibody: PGC1α Recombinant Rabbit mAb at 1/5000 dilution
Lane 1: rat kidney lysate 20 µg
Lane 2: rat heart lysate 20 µg
Secondary antibody: Goat Anti-Rabbit IgG, (H+L), HRP conjugated at 1/10000 dilution Predicted MW: 91 kDa
Observed MW: 110 kDa

Customer Reviews

Be the first to write a review
0%
(0)
0%
(0)
0%
(0)
0%
(0)
0%
(0)